يعرض 1 - 10 نتائج من 48 نتيجة بحث عن '"FDA, US food and drug administration"', وقت الاستعلام: 1.46s تنقيح النتائج
  1. 1
    كتاب إلكتروني
  2. 2

    المؤلفون: Erik De Clercq, Guangdi Li, Yali Wang

    المصدر: Acta Pharmaceutica Sinica B. 12:1567-1590

    وصف الملف: Print-Electronic

  3. 3
  4. 4

    المصدر: Bioactive Materials, Vol 6, Iss 11, Pp 4163-4175 (2021)
    Bioactive Materials

  5. 5

    المصدر: Acta Pharmaceutica Sinica B, Vol 11, Iss 8, Pp 2469-2487 (2021)
    Acta Pharmaceutica Sinica. B

  6. 6

    المصدر: Mayo Clinic Proceedings

  7. 7
  8. 8

    المصدر: Acta Pharmaceutica Sinica. B
    Acta Pharmaceutica Sinica B, Vol 11, Iss 12, Pp 3857-3868 (2021)

  9. 9

    المصدر: Acta Pharmaceutica Sinica. B
    Guo, Y, Bera, H, Shi, C, Zhang, L, Cun, D & Yang, M 2021, ' Pharmaceutical strategies to extend pulmonary exposure of inhaled medicines ', Acta Pharmaceutica Sinica B, vol. 11, no. 8, pp. 2565-2584 . https://doi.org/10.1016/j.apsb.2021.05.015Test
    Acta Pharmaceutica Sinica B, Vol 11, Iss 8, Pp 2565-2584 (2021)

    مصطلحات موضوعية: PLA, polylactic acid, MPP, mucus-penetrating particles, PLGA, poly(lactic-co-glycolic acid), Review, CS, chitosan, Pulmonary exposure, MW, molecular weight, PVA, polyvinyl alcohol, 0302 clinical medicine, Inhaled sustained release formulations, BALF, bronchoalveolar lavage fluid, General Pharmacology, Toxicology and Pharmaceutics, Patient compliance, COPD, chronic obstructive pulmonary diseases, HA, hyaluronic acid, DPIs, dry powder inhalers, 0303 health sciences, DPPC, dipalmitoylphosphatidylcholine, FDA, US food and drug administration, medicine.anatomical_structure, 030220 oncology & carcinogenesis, Obstructive Pulmonary Diseases, API, active pharmaceutical ingredient, NLCs, nanostructured lipid carriers, Clearance, medicine.medical_specialty, LABA, long-acting β2-adrenoceptor agonist, RM1-950, IL-5, interleukin-5, PCL, poly-ε-caprolactone, 03 medical and health sciences, LPPs, large porous particles, medicine, FDKP, fumaryl diketopiperazine, Intensive care medicine, Pharmaceutical strategies, Systemic diseases, Da, aerodynamic diameters, 030304 developmental biology, Asthma, PEG, polyethylene glycol, Lung, PVA - Polyvinyl alcohol, business.industry, DSPC, 1,2-distearoyl-sn-glycero-3-phosphocholine, Therapeutic effect, Drug administration, Pulmonary clearance pathways, MP, mucoadhesive particles, medicine.disease, Pulmonary drug delivery, SLNs, solid lipid nanoparticles, PDD, pulmonary drug delivery, Tmax, time of maximum concentration, ALIS, amikacin liposomal inhalation suspension, Mn, number-average molecular weight, MDIs, metered dose inhalers, Pulmonary safety, IL-4, interleukin-4, MCE, mucociliary escalator, PK, pharmacokinetics, Therapeutics. Pharmacology, ELF, epithelial lining fluid, business, Local lung diseases

    وصف الملف: application/pdf

  10. 10

    المؤلفون: Khaled M. Nada, Shawn P.E. Nishi

    المصدر: Mayo Clinic Proceedings: Innovations, Quality & Outcomes, Vol 5, Iss 1, Pp 177-186 (2021)
    Mayo Clinic Proceedings: Innovations, Quality & Outcomes